Landscape Capital Management L.L.C. Sells 9,735 Shares of Option Care Health, Inc. $OPCH

Key Points

• Landscape Capital Management L.L.C. has decreased its stake in Option Care Health by 32.7%, selling 9,735 shares and holding 20,040 shares worth approximately $700,000.
• Several hedge funds, including Northwestern Mutual Wealth Management Co. and Bessemer Group Inc., have significantly increased their investments in Option Care Health, showcasing a strong interest from institutional investors.
• Option Care Health reported a quarterly earnings per share of $0.41, exceeding estimates, with year-over-year revenue growth of 15.4% and set a guidance for FY 2025 EPS between 1.650 to 1.720.

Landscape Capital Management L.L.C. trimmed its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 32.7% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 20,040 shares of the company's stock after selling 9,735 shares during the quarter. Landscape Capital Management L.L.C.'s holdings in Option Care Health were worth $700,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Option Care Health by 1,492.9% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock worth $31,000 after acquiring an additional 836 shares in the last quarter. Brooklyn Investment Group raised its holdings in shares of Option Care Health by 186.6% during the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock worth $42,000 after acquiring an additional 780 shares in the last quarter. Public Employees Retirement System of Ohio raised its holdings in shares of Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after acquiring an additional 332 shares in the last quarter. Bessemer Group Inc. raised its holdings in shares of Option Care Health by 62.3% during the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock worth $54,000 after acquiring an additional 599 shares in the last quarter. Finally, Wealthquest Corp purchased a new stake in shares of Option Care Health during the 1st quarter worth approximately $66,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Stock Performance

NASDAQ:OPCH opened at $28.68 on Friday. The stock's fifty day moving average is $29.60 and its 200 day moving average is $31.65. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The firm has a market capitalization of $4.65 billion, a PE ratio of 22.94, a PEG ratio of 1.75 and a beta of 0.79. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same quarter in the prior year, the firm posted $0.30 EPS. Option Care Health's quarterly revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, sell-side analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 36,000 shares of Option Care Health stock in a transaction on Wednesday, August 20th. The shares were acquired at an average price of $27.15 per share, for a total transaction of $977,400.00. Following the completion of the purchase, the director directly owned 375,390 shares in the company, valued at approximately $10,191,838.50. This trade represents a 10.61% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Timothy P. Sullivan bought 20,000 shares of Option Care Health stock in a transaction on Thursday, August 21st. The stock was acquired at an average price of $27.51 per share, for a total transaction of $550,200.00. Following the purchase, the director owned 49,229 shares of the company's stock, valued at approximately $1,354,289.79. This trade represents a 68.43% increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 0.64% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the company. Barrington Research reaffirmed an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a report on Thursday, July 10th. JMP Securities upped their price objective on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a report on Thursday, July 31st. Finally, Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. Eight investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, Option Care Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $35.75.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.